The clinical significance of the change of serum HER2/neu concentration during neoadjuvant chemotherapy of the HER2-overexpressed breast cancer / 中华内分泌外科杂志
Chinese Journal of Endocrine Surgery
; (6): 368-370,383, 2013.
Article
em Zh
| WPRIM
| ID: wpr-624765
Biblioteca responsável:
WPRO
ABSTRACT
Objective To explore the change of serum HER2/neu concentration during neoadjuvant chemotherapy for HER2-overexpressed breast cancer and its correlation with the response to the neoadjuvant chemotherapy.Methods The concentration of the serum HER2/neu in 78 cases of HER2-overexpressed advanced breast cancer treated with neoadjuvant chemotherapy were detected with enzyme-linked immunosordent assay(ELISA).The relationship between the serum HER2/neu concentration and the response of neoadjuvant chemotherapy was analyzed.Results The serum HER2/neu concentration of befor and after neoadjuvant chemotherapy was 18.6 ± 10.0ng/ml,11.6 ± 6.lng/ml respectively.The serum HER2/neu concentration decreased significantly(P < 0.001).The response of neoadjuvant chemotherapy was correlated with the change of the serum HER2/neu concentration.The pathologic complete response was correlated with the serum HER2/neu concentration of prechemotherapy and the change of the serum HER2/neu concentration.Conclusion The change of serum HER2/neu concentration may serve as a marker predicting the response of neoadjuvant chemotherapy in HER2-overexpressed breast cancer.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Ano de publicação:
2013
Tipo de documento:
Article